Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.

  • Authors : Chan YH; ASTAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research, Singapore, Singapore.; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.

  • Source: Frontiers in immunology [Front Immunol] 2021 Jun 28; Vol. 12, pp. 680188. Date of Electronic Publication: 2021 Jun 28 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Yansuanmalingua inhibits replication of type 2 porcine reproductive and respiratory syndrome virus via activating the caspase-8 apoptosis pathway.

  • Authors : Ding Y; College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, Gansu, China.; State Key Laboratory of Veterinary Etiological Biology, National Foot-and-Mouth Disease Reference Laboratory, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu, China.

  • Source: Journal of basic microbiology [J Basic Microbiol] 2020 May; Vol. 60 (5), pp. 400-406. Date of Electronic Publication: 2020 Mar 01.Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 8503885 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Safety, pharmacokinetics and pharmacodynamics of TQ-A3334, an oral toll-like receptor 7 agonist in healthy individuals.

  • Authors : Hu Y; Phase I Clinical Research Center, the First Hospital of Jilin University, Jilin, China.; Zhang H

  • Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2021 Mar; Vol. 30 (3), pp. 263-269. Date of Electronic Publication: 2021 Jan 13.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Randomised clinical trial: safety, efficacy and pharmacokinetics of HS-10234 versus tenofovir for the treatment of chronic hepatitis B infection.

  • Authors : Zhang H; Phase I Clinical Research Center, The First Hospital of Jilin University, Jilin, China.; Hu Y

  • Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jan; Vol. 53 (2), pp. 243-252. Date of Electronic Publication: 2020 Nov 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase.

  • Authors : Zhao Q; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; Liu K

  • Source: Antiviral research [Antiviral Res] 2020 Dec; Vol. 184, pp. 104953. Date of Electronic Publication: 2020 Oct 13.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Peptides to combat viral infectious diseases.

  • Authors : Al-Azzam S; Professional Scientific Services, Eurofins Lancaster Laboratories, Lancaster, PA, 17605, USA.; Ding Y

  • Source: Peptides [Peptides] 2020 Dec; Vol. 134, pp. 170402. Date of Electronic Publication: 2020 Sep 01.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 8008690 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Safety, pharmacokinetics and pharmacodynamics of SYN023 alone or in combination with a rabies vaccine: An open, parallel, single dose, phase 1 bridging study in healthy Chinese subjects.

  • Authors : Ding Y; Phase I Clinical Unit, First Hospital, Jilin University, Changchun, Jilin, 130021, China.; Wu M

  • Source: Antiviral research [Antiviral Res] 2020 Dec; Vol. 184, pp. 104956. Date of Electronic Publication: 2020 Oct 19.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

[Clinical considerations in the design of clinical trial for innovative hepatitis B drugs].

  • Authors : Niu JQ; Department of Hepatobiliary Pancreatic Medicine & Phase I Drug Clinical Trial Ward, The First Hospital of Jilin University, Changchun 130021, China.; Zhang H

  • Source: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2020 Aug 20; Vol. 28 (8), pp. 654-657.Publisher: Chongqing yi ke da xue, di 2 lin chuang xue yuan Bing du xing gan yan yan jiu suo Country of Publication: China NLM ID: 9710009 Publication Model:

Record details

×
Academic Journal

Recurrent membranous nephropathy and acute cellular rejection in a patient treated with direct anti-HCV therapy (ledipasvir/sofosbuvir).

  • Authors : Murakami N; Schuster Transplant Research Center, Brigham and Women's Hospital, Boston, Massachusetts.; Ding Y

  • Source: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2018 Oct; Vol. 20 (5), pp. e12959. Date of Electronic Publication: 2018 Jul Publisher: Munksgaard Country of Publication: Denmark NLM ID: 100883688 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Bioactive Indolyl Diketopiperazines from the Marine Derived Endophytic Aspergillus versicolor DY180635.

  • Authors : Ding Y; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China.; Zhu X

  • Source: Marine drugs [Mar Drugs] 2020 Jun 28; Vol. 18 (7). Date of Electronic Publication: 2020 Jun 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101213729 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-3397

Record details

×
  • 1-10 of  137 results for ""Ding, Y.""